Towa Pharmaceutical Co., Ltd.
JPX: 4553.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Itsuro Yoshida
- Employees
- 4,588
- Headquarters
- Osaka, Japan
- IPO year
- 2004
- Market cap
- ¥192.5B
- Website
- https://www.towayakuhin.co.jp
Loading 4553…
Loading profile data…Frequently asked questions about 4553
What does Towa Pharmaceutical Co., Ltd. (4553.T) do?
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, a...
Where does 4553.T trade?
Towa Pharmaceutical Co., Ltd. (4553.T) trades on the Tokyo Stock Exchange.
What sector is 4553.T in?
Towa Pharmaceutical Co., Ltd. (4553.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Towa Pharmaceutical Co., Ltd.?
Itsuro Yoshida is the chief executive officer of Towa Pharmaceutical Co., Ltd. (4553.T).
Where is Towa Pharmaceutical Co., Ltd. headquartered?
Towa Pharmaceutical Co., Ltd. is headquartered in Japan.
Does 4553.T pay a dividend?
Yes — Towa Pharmaceutical Co., Ltd. (4553.T) paid a trailing twelve-month dividend of JPY 80.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4553.T go public?
Towa Pharmaceutical Co., Ltd. (4553.T) completed its initial public offering in 2004.